[1] Identity and localization of advanced glycation end products on human beta2-microglobulin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Cocklin RR, Zhang Y, O'Neill KD, Chen NX, Moe SM, Bidasee KR, Wang M.
Anal Biochem. 2003 Mar 15;314(2):322-5. [
PMID: 12654321]
[2] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.
Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA.
Mol Cell Proteomics. 2013 Mar;12(3):825-31. [
PMID: 23266961]
[3] Glycation of human beta 2-microglobulin in patients with hemodialysis-associated amyloidosis: identification of the glycated sites.
Miyata T, Inagi R, Wada Y, Ueda Y, Iida Y, Takahashi M, Taniguchi N, Maeda K.
Biochemistry. 1994 Oct 11;33(40):12215-21. [
PMID: 7918443]
[4] Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells.
Pavone B, Bucci S, Sirolli V, Merlini G, Del Boccio P, Di Rienzo M, Felaco P, Amoroso L, Sacchetta P, Di Ilio C, Federici G, Urbani A, Bonomini M.
Mol Biosyst. 2011 Mar;7(3):651-8. [
PMID: 21107472]